LIBRIUM (CHLORDIAZEPOXIDE HYDROCHLORIDE) — FDA Approval ANDA085461 (BAUSCH)
LIBRIUM (CHLORDIAZEPOXIDE HYDROCHLORIDE) — FDA Approval ANDA085461 (BAUSCH) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LIBRIUM; Active ingredients: CHLORDIAZEPOXIDE HYDROCHLORIDE; Application number: ANDA085461.
| Brand name | LIBRIUM |
|---|---|
| Active ingredients | CHLORDIAZEPOXIDE HYDROCHLORIDE |
| Application number | ANDA085461 |
| Sponsor | BAUSCH |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 19770921 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →